查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1446444

羊膜穿刺針市場規模、佔有率、趨勢分析報告：按類型、程序、最終用途、地區和細分市場預測，2024-2030

Amniocentesis Needle Market Size, Share & Trends Analysis Report By Type (100 to 150 mm, Smaller Than 100 mm, and Larger Than 150 mm), By Procedure, By End-use, By Region, and Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

羊膜穿刺針市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球羊膜穿刺針市場規模將達到2.9735億美元，複合年成長率為6.85%。

這一成長可歸因於多種因素，包括醫療技術的進步、遺傳性疾病盛行率的上升推動產前診斷需求的增加以及微創技術的持續發展。羊膜穿刺針的需求量很大，因為它們對於識別潛在風險至關重要。然而，婦產科領域對羊膜穿刺術後早期妊娠流產的迫切關注。

全球遺傳疾病數量的增加，導致產前診斷對羊膜穿刺針等精密工具的需求顯著增加。此類遺傳性疾病的日益流行凸顯了對胎兒潛在問題的準確和早期檢測方法的迫切需求。由於遺傳疾病對健康的嚴重影響，對更好的產前護理的需求不斷成長，凸顯了羊膜穿刺針等先進工具的重要性。例如，MJH Life Sciences 的 2022 年報告強調了全球日益沉重的遺傳疾病負擔，指出每年約有 30 萬嬰兒出生時患有鐮狀細胞病，佔世界人口的 5.5%。做作的。

女性普遍傾向將生育延後到高齡生產。隨著母親年齡的成長，胎兒染色體異常的風險增加，使得羊膜穿刺成為重要的診斷工具。羊膜穿刺術後早期流產的發生是婦產科領域的重要關注點。釐清這現象背後的因素極為重要。研究報告了不同的發生率，有些研究顯示發生率高達 10% 左右。因此，這與年齡相關的因素極大地推動了對羊膜穿刺針的需求。

此外，孕婦糖尿病和高血壓等慢性疾病的盛行率不斷上升，增加了對更全面的產前篩檢的需求。根據全球婦女醫學圖書館2021年發表的研究論文估計，根據世界衛生組織的標準，全球約16.9%的懷孕在懷孕期間受到高血糖的影響。由於肥胖率上升、母親老化以及篩檢和診斷標準的變化，這些病理的發生率正在上升。此外，醫學專業人士越來越認知到早期檢測遺傳疾病的重要性。因此，經常建議面臨這些健康挑戰的女性進行羊膜穿刺術，並提供評估胎兒健康的重要方法。

羊膜穿刺針市場報告亮點

  • 2023年，100-150mm細分市場佔據最大市場佔有率。這可能是由於最佳長度可以滿足產前手術中不同的臨床要求。
  • 由於對準確可靠的產前診斷的需求不斷成長以及遺傳異常盛行率的增加，羊膜穿刺術在 2023 年的手術領域中佔據主導地位。
  • 2023 年的最終使用領域主要由醫院領域主導，因為醫院提供包括羊膜穿刺術在內的全面產前服務，並且是這些針頭的主要使用者。
  • 由於先進的醫療基礎設施、產前檢測意識的提高、先進醫療技術採用率的提高以及遺傳異常盛行率的上升，北美地區在 2023 年佔據了最大的市場佔有率。
  • 市場參與者已採取多項策略舉措來擴大產品覆蓋範圍並提高不同地區的可用性。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章羊膜穿刺針市場：變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 羊膜穿刺針市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 羊膜穿刺針市場：類型估算與趨勢分析

  • 定義和範圍
  • 類型市場佔有率，2018年及2030年
  • 細分儀表板
  • 按類型分類的全球羊膜穿刺針市場展望
  • 2018-2030年市場規模、預測與趨勢分析

第5章羊膜穿刺針市場：治療估算與趨勢分析

  • 定義和範圍
  • 2018年及2030年治療市場佔有率
  • 細分儀表板
  • 按程序分類的全球羊膜穿刺針市場展望
  • 2024-2030年市場規模、預測與趨勢分析

第6章 羊膜穿刺針市場：最終用途估計與趨勢分析

  • 定義和範圍
  • 2018 年及 2030 年最終用途市場佔有率
  • 細分儀表板
  • 以最終用途分類的全球羊膜穿刺針市場展望
  • 2024-2030年市場規模、預測與趨勢分析

第7章羊膜穿刺針市場：區域估計與趨勢分析

  • 2023 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商形勢
    • Smith's Medical
    • Biopsybell Srl
    • Integra LifeSciences
    • Laboratoire CCD
    • Cook Medical
    • RI.MOS. Srl
    • CooperSurgical
    • Medline
    • Rocket Medical
    • Becton Dickinson and Company
Product Code: GVR-4-68040-190-1

Amniocentesis Needle Market Growth & Trends:

The global amniocentesis needle market size is anticipated to reach USD 297.35 million by 2030, expanding at a CAGR of 6.85%, based on a new report by Grand View Research, Inc. This growth can be attributed to several factors like advancements in healthcare technology, a rising prevalence of genetic disorders prompting increased demand for prenatal diagnosis, and the continuous development of minimally invasive techniques. Amniocentesis needles are in high demand as they are essential for identifying potential risks. However, there is a pressing concern within the fields of obstetrics and gynecology regarding early pregnancy loss following amniocentesis.

The rise in genetic disorders worldwide is significantly boosting the demand for precise tools such as amniocentesis needles in prenatal diagnostics. This rising prevalence of genetic conditions highlights the pressing need for accurate and early detection methods for potential issues in unborn babies. The importance of advanced tools like amniocentesis needles is underscored by the growing demand for better prenatal care due to the serious health implications of genetic disorders. For instance, a 2022 report from MJH Life Sciences highlighted the escalating global burden of genetic diseases, revealing that around 300,000 babies are born with sickle cell disease annually, affecting nearly 5% of the world's population.

The trend of women delaying childbirth to older ages has gained prevalent traction. Advanced maternal age is inherently linked to a promoted risk of chromosomal abnormalities in the fetus, rendering amniocentesis comes in as a crucial diagnostic tool. The occurrence of early abortion following amniocentesis is a significant concern within the fields of obstetrics and gynecology. It's crucial to uncover the factors that contribute to this phenomenon. Studies have reported varying incidence rates, with some suggesting rates as high as around 10%. Consequently, this age-related factor significantly propels the demand for amniocentesis needles.

Furthermore, the increasing prevalence of chronic diseases such as diabetes and hypertension among expectant mothers has increased the demand for more comprehensive prenatal screening. According to a 2021 research paper published by The Global Library of Women's Medicine, it is estimated that approximately 16.9% of pregnancies worldwide are affected by hyperglycemia during pregnancy, as per WHO criteria. The incidence of such conditions is on the rise, attributed to factors like the increasing obesity rate, advanced maternal age, and changes in screening and diagnostic criteria. Moreover, healthcare professionals increasingly acknowledge the importance of early detection of genetic disorders. Thus, amniocentesis is frequently recommended for women dealing with these health challenges, providing a crucial means to assess fetal health.

Amniocentesis Needle Market Report Highlights:

  • In 2023, the 100-150 mm segment accounted for the largest market share. This can be attributed due to its optimal length, which caters to diverse clinical requirements in prenatal procedures
  • The amniocentesis procedures segment dominated the procedure segment in 2023 owing to the rising demand for accurate and reliable prenatal diagnosis and increasing prevalence of genetic abnormalities
  • Hospitals segment dominated the end use segment in 2023 as they offer comprehensive prenatal services, including amniocentesis, making them key users of these needles
  • The North American region held the largest share of the market in 2023 due to advanced healthcare infrastructure, increased awareness about prenatal testing, higher adoption rates of advanced medical technologies, and a rising prevalence of genetic disorders
  • Market players adopt several strategic initiatives to increase the product reach and improve availability in diverse geographic areas

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Procedure
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Procedure outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Amniocentesis Needle Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising incidence of gestational diabetes
      • 3.2.1.2. Increasing prevalence of genetic disorders and chromosomal abnormalities
      • 3.2.1.3. Rise in prenatal testing
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk and invasiveness
      • 3.2.2.2. Alternative non-invasive testing
  • 3.3. Amniocentesis Needle Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Amniocentesis Needle Market: Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. 100 to 150 mm
    • 4.1.2. Larger Than 150 mm
    • 4.1.3. Smaller Than 100 mm
  • 4.2. Type Market Share, 2018 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Amniocentesis Needle Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. 100 to 150 mm
      • 4.5.1.1. 100 to 150 mm market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.2. Smaller Than 100 mm
      • 4.5.2.1. Smaller Than 100 mm market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Larger Than 150 mm
      • 4.5.3.1. Larger Than 150 mm market estimates and forecast 2018 to 2030s (USD Million)

Chapter 5. Amniocentesis Needle Market: Procedure Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Amniocentesis Procedures
    • 5.1.2. Amnioreduction Procedures
    • 5.1.3. Fetal Blood Transfusion
    • 5.1.4. Amnioinfusion Procedure
    • 5.1.5. Cordocentesis Procedure
  • 5.2. Procedure Market Share, 2018 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Amniocentesis Needle Market by Procedure Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 5.5.1. Amniocentesis Procedures
      • 5.5.1.1. Amniocentesis procedures market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. Amnioreduction Procedures
      • 5.5.2.1. Amnioreduction procedures market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.3. Fetal Blood Transfusion
      • 5.5.3.1. Fetal blood transfusion market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.4. Amnioinfusion Procedure
      • 5.5.4.1. Amnioinfusion procedure market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.5. Cordocentesis Procedure
      • 5.5.5.1. Cordocentesis Procedure market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Amniocentesis Needle Market: End-use Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Hospitals
    • 6.1.2. Diagnostics Centers
    • 6.1.3. Clinics
    • 6.1.4. Others
  • 6.2. End-use Market Share, 2018 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Amniocentesis Needle Market by End-use Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2024 to 2030 for the following
    • 6.5.1. Hospitals
      • 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.2. Diagnostic Centers
      • 6.5.2.1. Diagnostic centers market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.3. Clinics
      • 6.5.3.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Others
      • 6.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Amniocentesis Needle Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement scenario
      • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement scenario
      • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Competitive scenario
      • 7.8.3.3. Regulatory framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Smith's Medical
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Biopsybell Srl
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Integra LifeSciences
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Laboratoire CCD
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cook Medical
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. RI.MOS. Srl
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CooperSurgical
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Medline
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Rocket Medical
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Becton Dickinson and Company
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of regulatory bodies for different countries
  • Table 2 Key companies' product launches
  • Table 3 Key companies' merger and acquisitions
  • Table 4 Key companies' collaboration
  • Table 5 Other strategic initiatives of companies
  • Table 6 North America amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 9 North America amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 12 U.S. amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 15 Canada amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Europe amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 17 Europe amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 18 Europe amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 19 Europe amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 UK amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 22 UK amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 25 Germany amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 France amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 27 France amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 28 France amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Italy amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 30 Italy amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 31 Italy amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Spain amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 33 Spain amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 34 Spain amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Norway amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 36 Norway amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 37 Norway amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 39 Sweden amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 40 Sweden amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Denmark amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 42 Denmark amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 43 Denmark amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Japan amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 50 Japan amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 51 China amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 52 China amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 53 China amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 India amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 55 India amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 56 India amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Australia amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 59 Australia amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 62 South Korea amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Thailand amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 64 Thailand amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 65 Thailand amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 67 Latin America amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 68 Latin America amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 69 Latin America amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 71 Brazil amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 72 Brazil amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 74 Mexico amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 75 Mexico amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 78 Argentina amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa amniocentesis needle market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 85 South Africa amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 91 UAE amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait amniocentesis needle market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait amniocentesis needle market, by procedure, 2018 - 2030 (USD Million)
  • Table 94 Kuwait amniocentesis needle market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Amniocentesis needle market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement process
  • Fig. 4 Primary research pattern
  • Fig. 5 Amniocentesis needle market snapshot, 2023 (USD Million)
  • Fig. 6 Segment snapshot, USD Million
  • Fig. 7 Competitive landscape snapshot
  • Fig. 8 Penetration & growth prospect mapping, by product
  • Fig. 9 Market driver analysis (Current & future impact)
  • Fig. 10 Market restraint analysis (Current & future impact)
  • Fig. 11 Amniocentesis needle market, type outlook key takeaways (USD Million)
  • Fig. 12 Amniocentesis needle market: type movement analysis (USD Million), 2023 & 2030
  • Fig. 13 100 to 150 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Smaller than 100 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Larger than 150 mm amniocentesis needle market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Amniocentesis needle market: procedure movement analysis (USD Million), 2023 & 2030
  • Fig. 17 Amniocentesis procedures market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Amnioreduction procedures market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Fetal blood transfusion market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Amnioinfusion procedure market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Cordocentesis procedure market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Amniocentesis needle market, end use outlook key takeaways (USD Million)
  • Fig. 23 Amniocentesis needle market: End use movement analysis (USD Million), 2023 & 2030
  • Fig. 24 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Diagnostics centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Amniocentesis needle market: Regional key takeaways (USD Million)
  • Fig. 29 Amniocentesis needle market: Regional outlook, 2023 & 2030, USD Million
  • Fig. 30 North America amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 China amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Mexico amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait amniocentesis needle market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 List of key emerging company's/technology disruptors/innovators